Pharmaceutical Company CEO Developing $100 Alternative To EpiPen After 'Shameful' Price Hike
September 4, 2016
Mark Baum, CEO of Imprimis Pharmaceuticals who previously came out with a $1 alternative to Martin Shkreli's AIDS drug after 5000% price hike, is now going to take on Mylan and is plotting to offer a $100 EpiPen alternative.
Mark Baum / Imprimis Pharmceuticals
Baum believes the relentless EpiPen price hikes are "shameful" and plans to have a compounded version of the allergy treatment by the end of the year.
"I don't need to make $19 million a year," Baum said, referring to the big pay package Mylan's CEO Heather Bresch took home last year.
"Tonight when I go home I'm going to eat a nice piece of fish and the fish I eat isn't any better or worse than what she is going to eat."
Click Here For The Most Popular On Sunny Skyz
Football Player Asks Friend With Down Syndrome To Homecoming
'I Am Going To Die': Hero Doberman Saves 71-Year-Old Hiker From Charging Grizzly
Abandoned Bobcat Kitten Tries To Get Man To Adopt Her
This Post From Ricky Gervais Will Inspire You To Take A Risk
It Began With One Matching Batman Shirt Photo. 11 Years Later, They’re Still Doing It
8-Year-Old’s Dream Comes True As He Becomes A Firefighter For A Day
Football Player Asks Friend With Down Syndrome To Homecoming
Public Library’s Hilarious Trust Fall Fail Goes Viral
A Man Walks His Dog... Dressed As His Dog
Cat Rides 100 Miles On Roof Of Family Van — Refuses to Miss The Family Road Trip
Farmer Wakes Up To The Sweetest, Unexpected Surprise - A Newborn Donkey!
